Stay updated on Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.

Latest updates to the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page footer now shows Revision: v3.6.4, replacing v3.6.3, indicating a site version update.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision label was updated to v3.6.3, indicating a minor backend or documentation update; no user-facing content appears to be affected.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page's revision tag was updated to v3.6.2, reflecting a minor update to the page's revision history rather than substantive changes to study details.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now includes a 'No longer looking for participants' notice and new help sections, including 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and the 'Intervention/Treatment' topic. The revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check58 days agoChange DetectedThe page now shows revision v3.5.5, replacing the previous v3.5.4. This reflects an internal update to the site without altering study data or visible content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page revision tag was updated to v3.5.4, replacing the previous v3.5.3 to reflect a new version of the study record.SummaryDifference0.1%

Stay in the know with updates to Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-adjuvant Pembrolizumab in Stage IV Ovarian Cancer Clinical Trial page.